SEC 13F Intelligence

Versant Venture Management, LLC / OCUL

Versant Venture Management, LLC’s Ocular Therapeutix Inc Position

Does Versant Venture Management, LLC own Ocular Therapeutix Inc (OCUL)? Not currently — the last reported position was 1.47M shares worth $30M in Q4 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$30M
Q4 2020
Shares
1.47M
% of Portfolio
+3.15%
Quarters Held
9
position exited

Position History OCUL

Reported value by quarter
Q4 ’18: $8.8BQ4 ’18Q1 ’19: $8.8BQ2 ’19: $9.7BQ2 ’19Q3 ’19: $6.7BQ4 ’19: $8.8BQ4 ’19Q1 ’20: $11.0BQ2 ’20: $18.5BQ2 ’20Q3 ’20: $17MQ4 ’20: $30MQ4 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20201.47M$30M+3.15%
Q3 20202.22M$17M+3.09%
Q2 20202.22M$18.5B+2.65%
Q1 20202.22M$11.0B+3.01%
Q4 20192.22M$8.8B+2.64%
Q3 20192.22M$6.7B+2.61%
Q2 20192.22M$9.7B+2.84%
Q1 20192.22M$8.8B+2.90%
Q4 20182.22M$8.8B+4.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Versant Venture Management, LLC’s full portfolio or all institutional holders of OCUL.